Hypereosinophilic Syndrome
"Hypereosinophilic Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.
| Descriptor ID |
D017681
|
| MeSH Number(s) |
C15.378.553.231.549
|
| Concept/Terms |
Hypereosinophilic Syndrome- Hypereosinophilic Syndrome
- Hypereosinophilic Syndromes
- Syndrome, Hypereosinophilic
- Syndromes, Hypereosinophilic
Leukemia, Eosinophilic- Leukemia, Eosinophilic
- Eosinophilic Leukemia
- Eosinophilic Leukemias
- Leukemias, Eosinophilic
Loeffler's Endocarditis- Loeffler's Endocarditis
- Loefflers Endocarditis
- Endocarditis, Loeffler's
- Endocarditis, Loefflers
- Loeffler Endocarditis
- Endocarditis, Loeffler
Idiopathic Hypereosinophilic Syndrome- Idiopathic Hypereosinophilic Syndrome
- Hypereosinophilic Syndromes, Idiopathic
- Idiopathic Hypereosinophilic Syndromes
- Syndrome, Idiopathic Hypereosinophilic
- Syndromes, Idiopathic Hypereosinophilic
- Hypereosinophilic Syndrome, Idiopathic
|
Below are MeSH descriptors whose meaning is more general than "Hypereosinophilic Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Hypereosinophilic Syndrome".
This graph shows the total number of publications written about "Hypereosinophilic Syndrome" by people in this website by year, and whether "Hypereosinophilic Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 4 | 0 | 4 |
| 2019 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypereosinophilic Syndrome" by people in Profiles.
-
Transient left ventricular clot in COVID-19-related myocarditis is associated with hypereosinophilic syndrome: a case report. Int J Cardiovasc Imaging. 2021 Nov; 37(11):3279-3283.
-
A flare up of idiopathic hypereosinophilic syndrome due to COVID-19. Eur Heart J. 2021 03 01; 42(9):954.
-
Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up. BMJ Case Rep. 2021 Feb 04; 14(2).
-
Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. Chest. 2020 11; 158(5):e215-e219.
-
Morphologically proved ANCA positive Loeffler's pancarditis: medical and surgical treatment. Ter Arkh. 2019 May 16; 91(4):99-106.
-
[Hypereosinophilic syndrome and other rheumatic diseases with hypereosinophilia]. Z Rheumatol. 2019 May; 78(4):322-332.
-
Endomyocardial fibrosis complicating primary hypereosinophilic syndrome. Intensive Care Med. 2018 Dec; 44(12):2294-2295.
-
Acute Lymphoblastic Leukemia with Hypereosinophilia in a Child: Case Report and Literature Review. Int J Environ Res Public Health. 2018 06 04; 15(6).
-
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich's Syndrome. Front Immunol. 2018; 9:1198.
-
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRa kinase inhibitor for PDGFRa driving chronic eosinophilic leukemia. Eur J Med Chem. 2018 Apr 25; 150:366-384.